![](/img/cover-not-exists.png)
A Multi-Center, Randomized, Open-Label, Parallel Group Phase IV Trial Investigating the Outcome on Renal Function, Efficacy and Safety of CNI-Reduction or Elimination With Everolimus in De Novo Heart Transplant: Recipients: The MANDELA Study Design
Deuse, T., Bara, C., Barten, M., Hirt, S., Doesch, A., Knosalla, C., Grinninger, C., Stypmann, J., Porstner, M., Wimmer, P., Schulz, U.Volume:
34
Language:
english
Journal:
The Journal of Heart and Lung Transplantation
DOI:
10.1016/j.healun.2015.01.228
Date:
April, 2015
File:
PDF, 53 KB
english, 2015